|
JPH11503110A
(ja)
*
|
1995-02-17 |
1999-03-23 |
スミスクライン・ビーチャム・コーポレイション |
Ｉｌ−８受容体拮抗剤
|
|
US6054472A
(en)
*
|
1996-04-23 |
2000-04-25 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of IMPDH enzyme
|
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
|
US6211373B1
(en)
*
|
1996-03-20 |
2001-04-03 |
Smithkline Beecham Corporation |
Phenyl urea antagonists of the IL-8 receptor
|
|
WO1997044329A1
(en)
*
|
1996-05-20 |
1997-11-27 |
Teijin Limited |
Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
|
|
EP0907362A4
(en)
*
|
1996-06-27 |
1999-12-01 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
|
US6177448B1
(en)
|
1996-08-06 |
2001-01-23 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
JP2001523220A
(ja)
*
|
1996-08-06 |
2001-11-20 |
スミスクライン・ビーチャム・コーポレイション |
Ｉｌ―８受容体アンタゴニスト
|
|
EP0939634A4
(en)
*
|
1996-08-15 |
2001-02-21 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
|
US20020006405A1
(en)
*
|
1996-10-22 |
2002-01-17 |
Masaki Kitajima |
Sepsis remedy comprising anti-il-8 antibody as active ingredient
|
|
DE19651040C2
(de)
*
|
1996-12-09 |
1999-01-28 |
Bayer Ag |
Verfahren zur Herstellung von 2-Amino-5-alkyl-phenolen
|
|
HUP0001943A3
(en)
*
|
1997-01-23 |
2002-12-28 |
Smithkline Beecham Corp |
Benzimidazole and benzotriazole derivatives, their use, process for their preparation and pharmaceutical compositions containing them
|
|
US6436927B1
(en)
|
1997-02-12 |
2002-08-20 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
|
ES2224365T3
(es)
*
|
1997-02-12 |
2005-03-01 |
Smithkline Beecham Corporation |
Antagonistas de receptores de il-8.
|
|
US6696475B2
(en)
|
1997-04-22 |
2004-02-24 |
Neurosearch A/S |
Substituted phenyl derivatives, their preparation and use
|
|
US6344476B1
(en)
*
|
1997-05-23 |
2002-02-05 |
Bayer Corporation |
Inhibition of p38 kinase activity by aryl ureas
|
|
JP2002512633A
(ja)
*
|
1997-06-26 |
2002-04-23 |
イーライ・リリー・アンド・カンパニー |
抗血栓剤
|
|
JP2001512096A
(ja)
*
|
1997-07-29 |
2001-08-21 |
スミスクライン・ビーチャム・コーポレイション |
Ｉｌ−８レセプターアンタゴニスト
|
|
US7067117B1
(en)
|
1997-09-11 |
2006-06-27 |
Cambridge University Technical Services, Ltd. |
Compounds and methods to inhibit or augment an inflammatory response
|
|
US6989435B2
(en)
|
1997-09-11 |
2006-01-24 |
Cambridge University Technical Services Ltd. |
Compounds and methods to inhibit or augment an inflammatory response
|
|
AU2003204708B2
(en)
*
|
1997-12-22 |
2006-05-25 |
Bayer Healthcare Llc |
Inhibition of Raf Kinase using Substituted Heterocyclic Ureas
|
|
NZ505844A
(en)
*
|
1997-12-22 |
2003-10-31 |
Bayer Ag |
Inhibition of raf kinase using substituted heterocyclic ureas
|
|
US20080300281A1
(en)
*
|
1997-12-22 |
2008-12-04 |
Jacques Dumas |
Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
|
|
US7517880B2
(en)
*
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
|
HU227711B1
(en)
*
|
1997-12-22 |
2011-12-28 |
Bayer Healthcare Llc |
Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas and pharmaceutical compositions containing them
|
|
US7329670B1
(en)
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
|
EP1087661A4
(en)
*
|
1998-06-17 |
2003-04-16 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
|
KR20010106415A
(ko)
*
|
1998-07-23 |
2001-11-29 |
스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 |
Ｉｌ-8 수용체 길항제
|
|
JP2002523487A
(ja)
*
|
1998-08-28 |
2002-07-30 |
スミスクライン・ビーチャム・コーポレイション |
３−ヒドロキシ−４−アミノ−ベンゾニトリルの改良された合成方法
|
|
CN1263733C
(zh)
|
1998-10-22 |
2006-07-12 |
神经研究公司 |
取代苯基衍生物,它们的制备和用途
|
|
US6197803B1
(en)
|
1998-12-09 |
2001-03-06 |
American Home Products Corporation |
Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
|
|
IL143262A0
(en)
*
|
1998-12-09 |
2002-04-21 |
American Home Prod |
Thiourea inhibitors of herpes viruses
|
|
US6335350B1
(en)
|
1998-12-09 |
2002-01-01 |
American Home Products Corporation |
Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
|
|
US6207715B1
(en)
|
1998-12-09 |
2001-03-27 |
American Home Products Corporation |
Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a substituted phenylene-diamine group
|
|
CA2350833A1
(en)
*
|
1998-12-09 |
2000-06-15 |
Wyeth |
Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
|
|
US6255349B1
(en)
|
1998-12-09 |
2001-07-03 |
American Home Products Corporation |
Alph-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
|
|
US6201013B1
(en)
|
1998-12-09 |
2001-03-13 |
American Home Products Corporation |
Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
|
|
US6262090B1
(en)
|
1998-12-09 |
2001-07-17 |
American Home Products Corporation |
Aminopyridine-containing thiourea inhibitors of herpes viruses
|
|
US6166028A
(en)
*
|
1998-12-09 |
2000-12-26 |
American Home Products Corporation |
Diaminopuridine-containing thiourea inhibitors of herpes viruses
|
|
US20080269265A1
(en)
*
|
1998-12-22 |
2008-10-30 |
Scott Miller |
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
|
|
ATE538794T1
(de)
|
1999-01-13 |
2012-01-15 |
Bayer Healthcare Llc |
Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
|
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
US7928239B2
(en)
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
US7351834B1
(en)
*
|
1999-01-13 |
2008-04-01 |
Bayer Pharmaceuticals Corporation |
ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
WO2000042012A1
(en)
*
|
1999-01-13 |
2000-07-20 |
Bayer Corporation |
φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
|
|
UA73492C2
(en)
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
|
WO2000050425A1
(en)
|
1999-02-22 |
2000-08-31 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Polycyclo heterocyclic derivatives as antiinflammatory agents
|
|
ATE309237T1
(de)
|
1999-03-12 |
2005-11-15 |
Boehringer Ingelheim Pharma |
Aromatische heterozyklische verbindungen als antientzündungwirkstoffe
|
|
IL144897A0
(en)
|
1999-03-12 |
2002-06-30 |
Boehringer Ingelheim Pharma |
Compounds useful as anti-inflammatory agents
|
|
CN100352804C
(zh)
*
|
1999-03-17 |
2007-12-05 |
阿斯特拉曾尼卡有限公司 |
酰胺衍生物
|
|
CO5170528A1
(es)
*
|
1999-05-28 |
2002-06-27 |
Smithkline Beecham Corp |
Antagonistas de los receptores de la il-8 nistas del recpetor de la il-8
|
|
CO5190710A1
(es)
*
|
1999-06-15 |
2002-08-29 |
Smithkline Beecham Corp |
Antagonistas de un receptor de il-8 un receptor de il-8
|
|
CO5200760A1
(es)
*
|
1999-06-16 |
2002-09-27 |
Smithkline Beecham Corp |
Antagonistas del receptor de la il-8 ceptor il-8
|
|
KR20020029419A
(ko)
*
|
1999-07-07 |
2002-04-18 |
다비드 에 질레스 |
퀴나졸린 유도체
|
|
ATE312823T1
(de)
|
1999-07-09 |
2005-12-15 |
Boehringer Ingelheim Pharma |
Verfahren zur herstellung heteroarylsubstituierter ureaverbindungen
|
|
DE60024631T2
(de)
|
1999-07-26 |
2006-06-14 |
Banyu Pharma Co Ltd |
Biaryl-harnstoff-derivate
|
|
CO5271663A1
(es)
*
|
1999-11-09 |
2003-04-30 |
Smithkline Beecham Corp |
Antagonistas del receptor il-8
|
|
WO2001036403A1
(en)
*
|
1999-11-16 |
2001-05-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Urea derivatives as anti-inflammatory agents
|
|
US6525046B1
(en)
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
|
WO2001064165A2
(en)
*
|
2000-03-01 |
2001-09-07 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
MY133845A
(en)
*
|
2000-03-10 |
2007-11-30 |
Smithkline Beecham Corp |
Il-8 receptor antagonists
|
|
EP1261329A4
(en)
*
|
2000-03-10 |
2005-08-17 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
|
EP1274415A4
(en)
*
|
2000-03-14 |
2005-09-07 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
|
AR031098A1
(es)
*
|
2000-03-16 |
2003-09-10 |
Smithkline Beecham Corp |
Compuestos de hidroxifenil urea sustituidos con sulfonamidas, composiciones farmaceuticas que los comprenden, y uso de los mismos en la fabricacion de medicamentos para tratar una enfermedad mediada por una quimioquina
|
|
UY26627A1
(es)
|
2000-03-24 |
2001-09-28 |
Smithkline Beecham Corp |
Antagonistas de receptores de il-8
|
|
WO2001079168A1
(en)
*
|
2000-04-14 |
2001-10-25 |
Kureha Chemical Industry Co., Ltd. |
Nitrogenous compounds and antiviral drugs containing the same
|
|
MXPA02011868A
(es)
*
|
2000-05-30 |
2003-04-10 |
Smithkline Beecham Corp |
Antagonistas de receptor de interleucina 8.
|
|
NZ523659A
(en)
*
|
2000-07-18 |
2006-01-27 |
Smithkline Beecham Corp |
Use of IL-8 receptor antagonists in the treatment of virus infections
|
|
AU2001290852A1
(en)
*
|
2000-09-15 |
2002-03-26 |
Iconix Pharmaceuticals, Inc. |
Inhibitors of rho c
|
|
US7235576B1
(en)
|
2001-01-12 |
2007-06-26 |
Bayer Pharmaceuticals Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
US20040132694A1
(en)
*
|
2001-01-16 |
2004-07-08 |
Palovich Michael R. |
Il-8 receptor antagonists
|
|
US20040048897A1
(en)
*
|
2001-01-16 |
2004-03-11 |
Mccleland Brent |
Il-8 receptor antagonists
|
|
WO2002070467A1
(en)
|
2001-02-26 |
2002-09-12 |
4Sc Ag |
Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments
|
|
DE10109204A1
(de)
*
|
2001-02-26 |
2002-09-19 |
4Sc Ag |
Verbindungen zur Behandlung von Protozoen-Erkrankungen
|
|
ITMI20010395A1
(it)
*
|
2001-02-27 |
2002-08-27 |
Dompe Spa |
Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate
|
|
ATE479657T1
(de)
|
2001-02-28 |
2010-09-15 |
Univ Temple |
N-(aryl)-2-arylethensulfonamide und ihre therapeutischen anwendungen
|
|
US7371763B2
(en)
|
2001-04-20 |
2008-05-13 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
JPWO2002094261A1
(ja)
*
|
2001-05-24 |
2004-09-02 |
呉羽化学工業株式会社 |
含窒素化合物からなるｃｘｃｒ４拮抗作用を有する薬剤
|
|
US20040038854A1
(en)
*
|
2001-07-16 |
2004-02-26 |
Dillon Susan B. |
Use of il-8 receptor antagonists in the treatment of virus infections
|
|
US6791892B2
(en)
*
|
2001-07-18 |
2004-09-14 |
Samsung Electronics Co., Ltd. |
Method of generating an initializing signal during power-up of semiconductor memory device
|
|
ES2400070T3
(es)
*
|
2001-12-03 |
2013-04-05 |
Bayer Healthcare Llc |
Compuestos de aril-urea en combinación con otros agentes citostáticos o citotóxicos para tratamiento de cánceres humanos
|
|
US20080108672A1
(en)
*
|
2002-01-11 |
2008-05-08 |
Bernd Riedl |
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
|
|
MXPA04007832A
(es)
*
|
2002-02-11 |
2005-09-08 |
Bayer Pharmaceuticals Corp |
Aril-ureas con actividad inhibitoria de angiogenesis.
|
|
ATE529406T1
(de)
*
|
2002-02-11 |
2011-11-15 |
Bayer Healthcare Llc |
Aryl-harnstoffe als kinase inhibitoren
|
|
WO2003068229A1
(en)
*
|
2002-02-11 |
2003-08-21 |
Bayer Pharmaceuticals Corporation |
Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
|
|
US20040023961A1
(en)
*
|
2002-02-11 |
2004-02-05 |
Bayer Corporation |
Aryl ureas with raf kinase and angiogenisis inhibiting activity
|
|
WO2003072569A1
(en)
|
2002-02-25 |
2003-09-04 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
|
|
US7161031B2
(en)
*
|
2002-02-28 |
2007-01-09 |
Temple University - Of The Commonwealth System Of Higher Education |
Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
|
|
KR20030080509A
(ko)
*
|
2002-04-09 |
2003-10-17 |
주식회사 엘지생명과학 |
우레아, 티오우레아 및 설파마이드 유도체를 함유하는항균제 조성물
|
|
US20030236287A1
(en)
*
|
2002-05-03 |
2003-12-25 |
Piotrowski David W. |
Positive allosteric modulators of the nicotinic acetylcholine receptor
|
|
CA2493253A1
(en)
*
|
2002-08-01 |
2004-02-12 |
Neurosearch A/S |
Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
|
|
KR100863667B1
(ko)
*
|
2002-09-11 |
2008-10-15 |
가부시끼가이샤 구레하 |
아민 화합물 및 그 용도
|
|
EP1402887A1
(en)
*
|
2002-09-18 |
2004-03-31 |
Jerini AG |
New compounds for the inhibition of undesired cell proliferation and use thereof
|
|
MY143477A
(en)
|
2002-10-29 |
2011-05-31 |
Smithkline Beecham Corp |
Il-8 receptor antagonists
|
|
DE10251830A1
(de)
*
|
2002-11-07 |
2004-05-19 |
Wella Ag |
2-Amino-5-ethylphenol enthaltendes Mittel zum Färben von Keratinfasern
|
|
JP2006507329A
(ja)
*
|
2002-11-21 |
2006-03-02 |
ニューロサーチ、アクティーゼルスカブ |
新規アリールウレイド安息香酸誘導体及びその使用
|
|
AU2003300360A1
(en)
*
|
2002-12-20 |
2004-07-22 |
Migenix Corp. |
Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
|
|
US20060229335A1
(en)
*
|
2002-12-24 |
2006-10-12 |
Bradley Teegarden |
Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
|
|
US7220768B2
(en)
*
|
2003-02-11 |
2007-05-22 |
Wyeth Holdings Corp. |
Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus
|
|
NZ577553A
(en)
*
|
2003-02-21 |
2011-01-28 |
Resmed Ltd |
Nasal assembly
|
|
UY28213A1
(es)
*
|
2003-02-28 |
2004-09-30 |
Bayer Pharmaceuticals Corp |
Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
|
|
EP1457485A1
(en)
*
|
2003-03-14 |
2004-09-15 |
Dompé S.P.A. |
Sulfonic acids, their derivatives and pharmaceutical compositions containing them
|
|
EP1608319A4
(en)
*
|
2003-04-03 |
2007-02-28 |
Univ California |
IMPROVED HEMMER FOR SOLUBLE EPOXY HYDROLASE
|
|
EP1636585B2
(en)
|
2003-05-20 |
2012-06-13 |
Bayer HealthCare LLC |
Diaryl ureas with kinase inhibiting activity
|
|
HRP20060100T3
(en)
|
2003-07-22 |
2007-03-31 |
Arena Pharmaceuticals Inc |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
|
HRP20060073B1
(hr)
|
2003-07-23 |
2014-03-14 |
Bayer Healthcare Llc |
Fluoro supstituirana omega-karboksiaril difenil urea za lijeäśenje i prevenciju bolesti i stanja
|
|
CN1845726A
(zh)
|
2003-09-04 |
2006-10-11 |
波塞东医药公司 |
用于治疗心脏心律失常的erg通道开放剂
|
|
WO2005023238A1
(en)
*
|
2003-09-04 |
2005-03-17 |
Poseidon Pharmaceuticals A/S |
Erg channel openers for the treatment of hyperexcitability-related neuronal diseases
|
|
TW200530236A
(en)
|
2004-02-23 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Heteroaryl phenylurea
|
|
KR101149124B1
(ko)
*
|
2004-03-10 |
2012-05-25 |
가부시끼가이샤 구레하 |
아민계 염기성 화합물과 그의 용도
|
|
CA2559665A1
(en)
|
2004-03-16 |
2005-09-29 |
The Regents Of The University Of California |
Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids
|
|
CN1926114B
(zh)
*
|
2004-03-23 |
2011-08-24 |
艾尼纳制药公司 |
用于制备经取代n-芳基-n′-′3-(1h-吡唑-5-基)苯基脲及其中间体的方法
|
|
CA2561639A1
(en)
*
|
2004-03-29 |
2005-10-06 |
Neurosearch A/S |
Novel urea derivatives and their medical use
|
|
CN101010315A
(zh)
|
2004-04-30 |
2007-08-01 |
拜耳制药公司 |
用于治疗癌症的取代的吡唑基脲衍生物
|
|
US7326729B2
(en)
*
|
2004-05-12 |
2008-02-05 |
Schering Corporation |
CXCR1 and CXCR2 chemokine antagonists
|
|
JP2008500284A
(ja)
*
|
2004-05-12 |
2008-01-10 |
ブリストル−マイヤーズ スクイブ カンパニー |
血栓症の治療に有用なｐ２ｙ１レセプターのウレアアンタゴニスト
|
|
US7550499B2
(en)
|
2004-05-12 |
2009-06-23 |
Bristol-Myers Squibb Company |
Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
|
|
FR2872159B1
(fr)
*
|
2004-06-28 |
2007-10-05 |
Merck Sante Soc Par Actions Si |
Nouveaux derives acides carboxyliques phenyliques et leur utilisation dans le traitement du diabete
|
|
PL1778686T3
(pl)
|
2004-08-12 |
2009-04-30 |
Pfizer |
Pochodne triazolopirydynylosulfanylowe jako inhibitory kinazy MAP P38
|
|
EP1634573A1
(en)
*
|
2004-08-16 |
2006-03-15 |
The Procter and Gamble Company |
2-(Amino or substituted Amino)-5,6-substituted Phenol compounds, dyeing compositions containing them, and use thereof
|
|
WO2006023435A1
(en)
*
|
2004-08-16 |
2006-03-02 |
The Procter & Gamble Company |
2-(amino or substituted amino)-5, 6-substituted phenol compounds, dyeing compositions containing them, and use thereof
|
|
US20070249625A1
(en)
*
|
2004-10-20 |
2007-10-25 |
Jakob Busch-Petersen |
Il-8 Receptor Antagonists
|
|
ZA200703613B
(en)
*
|
2004-10-20 |
2009-05-27 |
Univ California |
Improved inhibitors for the soluble epoxide hydrolase
|
|
EP1809619A1
(en)
|
2004-10-21 |
2007-07-25 |
Transtech Pharma, Inc. |
Bissulfonamide compounds as agonists of galr1, compositions, and methods of use
|
|
SA05260357B1
(ar)
*
|
2004-11-19 |
2008-09-08 |
ارينا فارماسيتو تيكالز ، أنك |
مشتقات 3_فينيل_بيرازول كمعدلات لمستقبل سيروتينين 5_ht2a مفيدة في علاج الاضطرابات المتعلقه به
|
|
WO2006060762A2
(en)
*
|
2004-12-03 |
2006-06-08 |
Arena Pharmaceuticals, Inc. |
Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
EP1843762A1
(en)
*
|
2005-01-19 |
2007-10-17 |
Arena Pharmaceuticals, Inc. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis or treatment of progressive multifocal leukoencephalopathy
|
|
ATE499370T1
(de)
|
2005-01-19 |
2011-03-15 |
Bristol Myers Squibb Co |
2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3- aminderivate und verwandte verbindungen als p2y1- rezeptor-hemmer zur behandlung thromboembolischer erkrankungen
|
|
TW200700727A
(en)
*
|
2005-03-23 |
2007-01-01 |
Astrazeneca Ab |
Screen
|
|
US7714002B2
(en)
|
2005-06-27 |
2010-05-11 |
Bristol-Myers Squibb Company |
Carbocycle and heterocycle antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
|
|
DE602006017694D1
(de)
|
2005-06-27 |
2010-12-02 |
Bristol Myers Squibb Co |
C-verknüpfte zyklische antagonisten des p2y1-rezeptors mit eignung bei der behandlung thrombotischer leiden
|
|
ATE502924T1
(de)
|
2005-06-27 |
2011-04-15 |
Bristol Myers Squibb Co |
Lineare harnstoffmimetika-antagonisten des p2y1- rezeptors zur behandlung von thromboseleiden
|
|
KR20080027890A
(ko)
|
2005-06-27 |
2008-03-28 |
브리스톨-마이어스 스큅 컴퍼니 |
혈전성 증상의 치료에 유용한 ｐ2ｙ1 수용체의 ｎ-연결헤테로시클릭 길항제
|
|
GB0526255D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
US8741960B2
(en)
*
|
2006-01-25 |
2014-06-03 |
Synta Pharmaceuticals Corp. |
Substituted aromatic compounds for inflammation and immune-related uses
|
|
CA2650007A1
(en)
*
|
2006-04-21 |
2007-11-01 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
|
AR060562A1
(es)
*
|
2006-04-21 |
2008-06-25 |
Smithkline Beecham Corp |
Compuestos heterociclicos como antagonistas del receptor il-8. procesos de obtencion y composiciones farmaceuticas.
|
|
WO2007127930A2
(en)
*
|
2006-04-28 |
2007-11-08 |
Kansas State University Research Foundation |
Compounds affecting gap junction activity
|
|
CA2646076C
(en)
|
2006-05-18 |
2015-06-30 |
Arena Pharmaceuticals, Inc. |
Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
USRE45336E1
(en)
|
2006-05-18 |
2015-01-13 |
Arena Pharmaceuticals, Inc. |
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
|
|
WO2007136689A2
(en)
|
2006-05-18 |
2007-11-29 |
Arena Pharmaceuticals, Inc. |
Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
|
|
PE20080943A1
(es)
|
2006-06-23 |
2008-09-27 |
Smithkline Beecham Corp |
Sal toluenosulfonato de 4-{[6-cloro-3-({[(2-cloro-3-fluorofenil)amino]carbonil}amino)-2-hidroxifenil]sulfonil}-1-piperazinacarboxilato de 1,1-dimetiletilo como antagonista del receptor de il-8
|
|
TWI415845B
(zh)
*
|
2006-10-03 |
2013-11-21 |
Arena Pharm Inc |
用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
|
|
US7960569B2
(en)
|
2006-10-17 |
2011-06-14 |
Bristol-Myers Squibb Company |
Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
|
|
WO2008047067A1
(en)
*
|
2006-10-20 |
2008-04-24 |
University Court Of The University Of Edinburgh |
Treatment of inflammatory disease
|
|
EP2190844B3
(en)
|
2007-08-15 |
2013-07-17 |
Arena Pharmaceuticals, Inc. |
Imidazo[1,2-a]pyridine derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
MX2010003440A
(es)
*
|
2007-09-28 |
2010-04-21 |
Glaxosmithkline Llc |
Compuesto inhibidor de glicogeno fosforilasa y composicion farmaceutica del mismo.
|
|
WO2009123714A2
(en)
*
|
2008-04-02 |
2009-10-08 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
|
TR201805216T4
(en)
|
2008-10-28 |
2018-06-21 |
Arena Pharm Inc |
COMPOSITIONS OF A USEFUL 5-HT2A SEROTONINE RECEPTOR MODULATOR FOR THE TREATMENT OF RELATED DISORDERS
|
|
WO2010062321A1
(en)
|
2008-10-28 |
2010-06-03 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
|
|
WO2010092440A1
(en)
*
|
2009-02-16 |
2010-08-19 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Cxcr2 receptor antagonists for the treatment or the prevention of insulin resistance
|
|
US20120136033A1
(en)
*
|
2009-05-18 |
2012-05-31 |
President And Fellows Of Harvard College |
Small Molecule Antagonists of Phosphatidylinositol-3,4,5-Triphosphate (PIP3) and Uses Thereof
|
|
WO2011073248A1
(en)
*
|
2009-12-17 |
2011-06-23 |
Galderma Research & Development |
Use of compounds in the treatment or prevention of skin disorders
|
|
WO2011075596A1
(en)
|
2009-12-18 |
2011-06-23 |
Arena Pharmaceuticals, Inc. |
Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
BRPI1004176A2
(pt)
*
|
2010-10-25 |
2015-08-11 |
Univ Rio De Janeiro |
Compostos aril e/ou hetero aril uréias funcionalizados; processo de síntese desses composto; composição farmacêutica contendo tais compostos e usos
|
|
US8648118B2
(en)
|
2010-12-17 |
2014-02-11 |
Boehringer Ingelheim International Gmbh |
Bicyclic ring system substituted amide functionalised phenols as medicaments
|
|
JP6240063B2
(ja)
*
|
2011-04-28 |
2017-11-29 |
ザ ブロード インスティテュート， インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
|
CA2880117C
(en)
|
2012-07-27 |
2021-04-06 |
The Broad Institute, Inc. |
Inhibitors of histone deacetylase
|
|
CN104797429B
(zh)
*
|
2012-11-21 |
2017-04-19 |
日本曹达株式会社 |
使用非酚类化合物的记录材料、记录片和将非酚类化合物用于显色剂的方法
|
|
US9914717B2
(en)
|
2012-12-20 |
2018-03-13 |
The Broad Institute, Inc. |
Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
|
|
BR112015018750B1
(pt)
*
|
2013-02-13 |
2021-12-07 |
Oji Holdings Corporation |
Material de registro sensível ao calor
|
|
US9789721B2
(en)
|
2013-05-22 |
2017-10-17 |
Oji Holdings Corporation |
Thermosensitive recording medium
|
|
JP2018516992A
(ja)
|
2015-06-12 |
2018-06-28 |
アクソファント サイエンシーズ ゲーエムベーハーＡｘｏｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ |
レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体
|
|
EP3117835A1
(en)
*
|
2015-07-14 |
2017-01-18 |
Dompé farmaceutici s.p.a. |
Il-8 inhibitors for use in the treatment of certain urological disorders
|
|
WO2017011767A2
(en)
|
2015-07-15 |
2017-01-19 |
Axovant Sciences Ltd. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease
|
|
US10093617B1
(en)
*
|
2015-10-30 |
2018-10-09 |
Sumitomo Chemical Company, Limited |
Method for producing 2-amino-4-substituted phenol
|
|
WO2017219935A1
(zh)
*
|
2016-06-22 |
2017-12-28 |
复旦大学 |
联芳基脲类衍生物或其盐及其制备方法和用途
|
|
CN107522641B
(zh)
*
|
2016-06-22 |
2020-05-05 |
复旦大学 |
联芳基脲类衍生物或其盐及其制备方法和用途
|
|
CN117503933A
(zh)
|
2016-10-03 |
2024-02-06 |
儿童医疗中心公司 |
糖尿病肾病的预防和治疗
|
|
EP3737362B1
(en)
|
2018-01-12 |
2025-10-15 |
Kdac Therapeutics, Inc. |
Combination of a selective histone deacetylase 3 (hdac3) inhibitor and an immunotherapy agent for the treatment of cancer
|
|
CN110698373A
(zh)
*
|
2019-11-07 |
2020-01-17 |
温州大学 |
N-（2-（甲硫基）苯基）乙酰胺类化合物的制备方法及其净化提纯方法
|
|
CN112321452B
(zh)
*
|
2020-09-11 |
2022-11-29 |
北京红惠新医药科技有限公司 |
厚朴酚衍生物、和厚朴酚衍生物及其盐酸盐、制备方法及应用
|
|
WO2025121190A1
(ja)
*
|
2023-12-08 |
2025-06-12 |
日産化学株式会社 |
重合体、樹脂組成物、液晶配向剤、樹脂被膜及び液晶配向膜
|